OsteoRemedies gets expanded indication for dual antibiotic bone cement

OsteoRemedies got new FDA clearances for its Spectrum GV dual antibiotic bone cement, according to an April 23 news release.

Advertisement

The Spectrum bone cement’s new indications cover the fixation of revision hip arthroplasty components. It was launched in 2018 for total joint replacement.

Spectrum has vancomycin and gentamicin, which has antibacterial properties. 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.